Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Online First

August 04, 2020

Correspondence
Transient monoarthritis and psoriatic skin lesions following COVID-19
Free

Ludovico De Stefano, Silvia Rossi, Carlomaurizio Montecucco, Serena Bugatti

doi: 10.1136/annrheumdis-2020-218520
Correspondence
Correspondence on ‘2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus’ by Aringer et al

Ran Cui, Qian Wang, Hua Zhang, Shan Wu, Xin-Jian Wan, Sheng-Ming Dai

doi: 10.1136/annrheumdis-2020-218546
Correspondence response
Treatment of patients with inflammatory rheumatic diseases with rituximab should be carefully considered during the SARS-CoV-2/COVID-19 pandemic. Response to: ‘Persistence of rT-PCR-SARS-CoV-2 infection and delayed serological response, as a possible effect of rituximab according to the hypothesis of Schulze-Koops et al’ by Benucci et al
Free

Hendrik Schulze-Koops, Klaus Krueger, Inka Vallbracht Vallbracht, Rebecca Hasseli, Alla Skapenko

doi: 10.1136/annrheumdis-2020-218686
Correspondence response
Response to: ‘Correspondence to ‘Gender gap in rheumatology: speaker representation at annual conferences’ by Monga and Liew–gender discrepancies at annual EULAR congresses: towards the gap narrowing’ by Conigliaro et al
Free

Kanika Monga, Jean Liew

doi: 10.1136/annrheumdis-2020-218628
Correspondence
Association of subcutaneous belimumab and long-term antimalarial treatment reduces antiphospholipid antibodies levels in systemic lupus erythematosus: post-hoc analysis of a randomised placebo-controlled trial—comment on: ‘Effect of belimumab treatment on antiphospholipid antibody levels: post-hoc analysis based on two randomised placebo-controlled trials in systemic lupus erythematosus’ by Chatzidionysiou et al
Free

Alessandra Bettiol, Francesca Pregnolato, Savino Sciascia, Giacomo Emmi, Domenico Prisco, Pier Luigi Meroni

doi: 10.1136/annrheumdis-2020-218377
Correspondence response
Gastrointestinal SLE involvement in SLE classification. Response to: ‘‘2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus’ by Aringer et al’ by Cui et al
Free

Martin Aringer, Karen H Costenbader, Thomas Dörner, Sindhu R Johnson

doi: 10.1136/annrheumdis-2020-218615

July 31, 2020

Correspondence response
Targeting IL-6 in COVID-19. Response to: ‘Rational use of tocilizumab in COVID-19’ by Jain and Sharma
Free

Pier Leopoldo Capecchi, Pietro Enea Lazzerini

doi: 10.1136/annrheumdis-2020-218627
Correspondence
Comment on ‘Implication of baseline levels and early changes of C-reactive protein for subsequent clinical outcomes of patients with rheumatoid arthritis treated with tocilizumab’
Free

Attila Pethoe-Schramm, Jenny Devenport, William Reiss

doi: 10.1136/annrheumdis-2020-218365
Correspondence response
Response to: ‘Comment on ‘Implication of baseline levels and early changes of C-reactive protein for subsequent clinical outcomes of patients with rheumatoid arthritis treated with tocilizumab’’ by Pethoe-Schramm et al
Free

Inbal Haya Shafran, Farideh Alasti, Josef S Smolen, Daniel Aletaha

doi: 10.1136/annrheumdis-2020-218403
Correspondence response
Response to: ‘Rational use of tocilizumab in COVID-19’ by Jain and Sharma
Free

Nicola Potere, Marcello Di Nisio, Donatella Cibelli, Rosa Scurti, Antonella Frattari, Ettore Porreca, Antonio Abbate, Giustino Parruti

doi: 10.1136/annrheumdis-2020-218626
Correspondence
Rational use of tocilizumab in COVID-19
Free

Siddharth Jain, Shefali Khanna Sharma

doi: 10.1136/annrheumdis-2020-218519
Correspondence response
Targeting IL-1, IL-6 or GM-CSF in COVID-19. Response to: ‘More evidences on which biologic and which pathway is key in severe-critical COVID-19 pneumonia’ by Ferraccioli
Free

Emanuel Della-Torre, Corrado Campochiaro, Giulio Cavalli, Giacomo De Luca, Fabio Ciceri, Alberto Zangrillo, Lorenzo Dagna

doi: 10.1136/annrheumdis-2020-218612
Correspondence
More evidences on which biologic and which pathway is key in severe-critical COVID-19 pneumonia
Free

Gianfranco Ferraccioli

doi: 10.1136/annrheumdis-2020-218523

July 30, 2020

Correspondence
Comment on ‘Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 global rheumatology alliance physician-reported registry’ by Gianfrancesco M et al
Free

Ioana Andreica, David Kiefer, Guenther A Rezniczek, Robert Jast, Bjoern Buehring, Uta Kiltz, Xenofon Baraliakos, Juergen Braun

doi: 10.1136/annrheumdis-2020-218609

July 28, 2020

Correspondence
Can telerheumatology improve rheumatic and musculoskeletal disease service delivery in sub-Saharan Africa?
Free

Akpabio Akpabio, Richard Oluyinka Akintayo, Utibe Effiong

doi: 10.1136/annrheumdis-2020-218449
Correspondence response
Improving telemedicine and in-person management of rheumatic and autoimmune diseases,during and after COVID-19 pandemic outbreak. Definite need for more Rheumatologists. Response to: ‘Can telerheumatology improve rheumatic and musculoskeletal disease service delivery in sub-Saharan Africa?’ by Akpabio et al
Free

Francesco Caso, Antonio del Puente, Nicolò Girolimetto, Marco Tasso, Corrado Caso, Raffaele Scarpa, Luisa Costa

doi: 10.1136/annrheumdis-2020-218472

July 24, 2020

Correspondence response
Response to: ‘Comment on Ye et al ‘Presence of respiratory failure of COVID-19 infection in patients with rheumatism in Wuhan, China’’ by Chen et al
Free

Jixin Zhong, Cong Ye, Shaozhe Cai, Lingli Dong

doi: 10.1136/annrheumdis-2020-218508
Correspondence
Vital corner of diagnostic challenge: eosinophilic granulomatosis with polyangiitis or COVID-19 pneumonia?

Emine Duran, Levent Kilic, Gamze Durhan, Ahmet Çağkan Inkaya, Gulay Sain Guven, Gul Karakaya, Orhan Macit Ariyurek, Omer Karadag

doi: 10.1136/annrheumdis-2020-218533
Correspondence
Clinical features of patients with rheumatic diseases and COVID-19 infection in Sarawak, Malaysia
Free

Sharifah Aishah Wan, Cheng Lay Teh, Benjamin Sachdev Manjit Singh, Yaw Kiet Cheong, Seow Lin Chuah, Ahmad Tirmizi Jobli

doi: 10.1136/annrheumdis-2020-218425
Correspondence
Comment on Ye et al ‘Presence of respiratory failure of COVID-19 infection in rheumatism patients in Wuhan, China’
Free

Xiao-Huan Chen, Chih-Jung Yeh, Han-You Mo, James Cheng Chung Wei

doi: 10.1136/annrheumdis-2020-218451
Correspondence response
Response to: ‘Clinical features of patients with rheumatic diseases and COVID-19 infection in Sarawak, Malaysia’ by Wan et al
Free

Jixin Zhong, Lingli Dong

doi: 10.1136/annrheumdis-2020-218441

July 13, 2020

Correspondence response
Response to: ‘COVID-19 in patients with rheumatic diseases: what is the real mortality risk?’ by Marques et al
Free

Kristin M D’Silva, Naomi Serling-Boyd, Rachel Wallwork, Tiffany Y-T Hsu, Jeffrey A Sparks, Zachary Scott Wallace

doi: 10.1136/annrheumdis-2020-218431
Correspondence
COVID-19 in patients with rheumatic diseases: what is the real mortality risk?
Free

Claudia Marques, Marcelo M Pinheiro, Edgard Torres Reis Neto, Andrea Tavares Dantas, Francinne Machado Ribeiro, Ana Karla G Melo

doi: 10.1136/annrheumdis-2020-218388

July 10, 2020

Correspondence
‘Halo Score’: missing large-vessel giant cell arteritis— do we need a ‘modified Halo Score’?
Free

Arghya Chattopadhyay, Alakendu Ghosh

doi: 10.1136/annrheumdis-2020-218224
Correspondence response
Response to: ‘‘Halo Score’: missing large vessel giant cell arteritis– do we need a modified ‘Halo Score?’’ by Chattopadhyay and Ghosh
Free

Kornelis S M van der Geest, Bhaskar Dasgupta

doi: 10.1136/annrheumdis-2020-218262

July 09, 2020

Correspondence
Emergency arising from patients' fear of taking antimalarials during these COVID-19 times: are antimalarials as unsafe for cardiovascular health as recent reports suggest?
Free

Pedro Santos-Moreno, Diana Buitrago-Garcia, Laura Villarreal, Anggie Aza, Michael Cabrera, Wilberto Rivero, Adriana Rojas-Villarraga

doi: 10.1136/annrheumdis-2020-218259

July 06, 2020

Correspondence
Should patients starting biologics be screened for COVID-19?
Free

Jesus Alberto Cardenas-de la Garza, Rosa I Arvizu-Rivera, Dionicio Angel Galarza-Delgado

doi: 10.1136/annrheumdis-2020-218437
Correspondence
Serological tests confirm the low incidence of COVID-19 in chronic rheumatic inflammatory diseases treated with biological DMARD
Free

Maurizio Benucci, Arianna Damiani, Gianfranco Giannasi, Francesca Li Gobbi, Luca Quartuccio, Valentina Grossi, Maria Infantino, Mariangela Manfredi

doi: 10.1136/annrheumdis-2020-218214

July 02, 2020

Correspondence response
Response to: ‘Cutaneous adverse events with febuxostat after previous reactions to allopurinol: comment on the artcile by Singh and Clevland’ by Quills et al
Free

Jasvinder A Singh

doi: 10.1136/annrheumdis-2020-218263
Correspondence
Cutaneous adverse events with febuxostat after previous reactions to allopurinol: comment on the article by Singh and Cleveland
Free

Neus Quilis, Paloma Vela, Boris A Blanco Cáceres, Cesar Diaz-Torne, Enrique Calvo-Aranda, Francisca Sivera, Alejandro Prada-Ojeda, Fernando Pérez Ruiz, Eliseo Pascual, Mariano Andrés

doi: 10.1136/annrheumdis-2020-218226

June 26, 2020

Correspondence
Eosinophilic granulomatosis with polyangiitis can manifest lacrimal and salivary glands swelling by granulomatous inflammation: a potential mimicker of IgG4-related disease
Free

Mitsuhiro Akiyama, Yuko Kaneko, Tsutomu Takeuchi

doi: 10.1136/annrheumdis-2020-218124
Correspondence response
Response to: ‘Eosinophilic granulomatosis with polyangiitis can manifest lacrimal and salivary glands swelling by granulomatous inflammation: a potential mimicker of IgG4-related disease’ by Akiyama et al
Free

Augusto Vaglio, Federica Maritati, Jochen Zwerina

doi: 10.1136/annrheumdis-2020-218174

June 25, 2020

Correspondence response
Is a human in vitro enthesitis model relevant to SpA-associated enthesitis? Response to: ‘Beware of wolves in sheep's clothing: immune cell plasticity and instability in health and disease’ by Alunno et al
Free

Abdulla Watad, Hannah Rowe, Darren Newton, Charlie Bridgewood, Dennis G McGonagle

doi: 10.1136/annrheumdis-2020-218151
Correspondence
Incidence of severe COVID-19 in a Spanish cohort of 1037 patients with rheumatic diseases treated with biologics and JAK-inhibitors
Free

Vega Jovani, Irene Calabuig, Maria Luisa Peral-Garrido, Ernesto Tovar-Sugrañes, María-del-Carmen López-González, Pilar Bernabeu, Agustín Martínez, Joaquim Esteve-Vives, Jose-Manuel León-Ramírez, Oscar Moreno-Perez, Vicente Boix, Joan Gil, Esperanza Merino, Paloma Vela, Mariano Andrés

doi: 10.1136/annrheumdis-2020-218152
Correspondence response
Response to: ‘Incidence of severe COVID-19 in a Spanish cohort of 1037 patients with rheumatic diseases treated with biologics and JAK-inhibitors’ by Jovani et al
Free

Kristin M D’Silva, Naomi Serling-Boyd, Rachel Wallwork, Tiffany Hsu, Jeffrey A Sparks, Zachary S Wallace

doi: 10.1136/annrheumdis-2020-218179

June 19, 2020

Correspondence response
Hypersensitivity reactions with allopurinol versus febuxostat in the US elderly. Response to: ‘Confunding by indication and ethnicity difference? Comment on ‘Hypersensitivity reactions with allopurinol and febuxostat: a study using the Medicare claims data’’ by Hsu et al
Free

Jasvinder A Singh

doi: 10.1136/annrheumdis-2020-218150
Correspondence
Confounding by indication and ethnicity difference? Comment on ‘Hypersensitivity reactions with allopurinol and febuxostat: a study using the Medicare claims data’
Free

Po-Ke Hsu, Yung-Heng Lee, James Cheng Chung Wei

doi: 10.1136/annrheumdis-2020-218056

June 12, 2020

Correspondence
Beware of wolves in sheep's clothing: immune cell plasticity and instability in health and disease
Free

Alessia Alunno, Onelia Bistoni, Roberto Gerli

doi: 10.1136/annrheumdis-2020-218094

May 13, 2020

Correspondence
Gender gap in rheumatology: speaker representation at annual conferences
Free

Kanika Monga, Jean Liew

doi: 10.1136/annrheumdis-2020-217673

May 06, 2020

Correspondence
Severe polymyalgia-like symptoms secondary to anti-PD1 therapy successfully managed without discontinuing checkpoint inhibitor
Free

Carlos Antonio Moura, Carlos Geraldo Moura

doi: 10.1136/annrheumdis-2020-217605

Log in using your username and password

Main menu

Log in using your username and password

You are here

Online First

August 04, 2020

July 31, 2020

July 30, 2020

July 28, 2020

July 24, 2020

July 22, 2020

July 21, 2020

July 15, 2020

July 13, 2020

July 10, 2020

July 09, 2020

July 06, 2020

July 02, 2020

June 26, 2020

June 25, 2020

June 19, 2020

June 12, 2020

May 13, 2020

May 06, 2020

Pages